Skip to Main Content


Skip Nav Destination

Featured Content

Langerhans Cell Histiocytosis in the Adult: A Commentary on Diagnosis, Treatment, and Surveillance

Drs. Krishnan, Kiamos, Wang, Dodd, and Quan comment on the typical management course for Langerhans cell histiocytosis from diagnosis through treatment.

Is It an Ember or Is It a Flame?

Drs. Kumar and Rajkumar review the current state of smoldering myeloma treatments with an increasing understanding of the natural history of SMM and its underlying biology.

Daratumumab, Lenalidomide, and Dexamethasone for High-Risk Smoldering Multiple Myeloma

Drs. Tan and Usmani look at DETER-SMM, a randomized phase III clinical trial designed to examine the efficacy of DRd compared with Rd in high-risk smoldering multiple myeloma. 
Close Modal

or Create an Account

Close Modal
Close Modal